Different patterns of white matter disruption among amnestic mild cognitive impairment subtypes: relationship with

He Li1, Ying Liang, Kewei Chen

  • 1State Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, PR China.

Insights

Multiple-domain amnestic mild cognitive impairment (aMCI-MD) shows widespread white matter (WM) damage linked to cognitive decline. Single-domain aMCI (aMCI-SD) exhibits minimal WM changes, suggesting distinct disease progression pathways.

Area of Science:

  • Neuroimaging
  • Neurology
  • Alzheimer's Disease Research

Background:

  • Amnestic mild cognitive impairment (aMCI) is a precursor to Alzheimer's disease (AD).
  • Multiple-domain aMCI (aMCI-MD) carries a higher risk of dementia progression and shows greater gray matter loss than single-domain aMCI (aMCI-SD).
  • Understanding white matter (WM) microstructural changes in aMCI subtypes is crucial for identifying biomarkers and monitoring disease progression.

Purpose of the Study:

  • To investigate white matter (WM) microstructural abnormalities in aMCI subtypes (aMCI-MD vs. aMCI-SD) using diffusion-weighted MRI.
  • To explore the relationship between altered WM integrity and cognitive performance in each aMCI subtype.
  • To differentiate the pathological profiles of aMCI-MD and aMCI-SD.

Main Methods:

  • Diffusion-weighted MRI data analyzed using voxel-wise and atlas-based approaches in 40 aMCI patients (19 aMCI-SD, 21 aMCI-MD) and 37 healthy controls (HC).
  • Comparison of WM diffusion metrics across the three groups.
  • Correlation analysis between diffusion metrics and neuropsychological scores (MMSE, Digit Symb-Coding) within aMCI subtypes.

Main Results:

  • aMCI-MD patients exhibited significantly disrupted WM integrity in multiple tracts compared to HC and aMCI-SD.
  • aMCI-SD showed only minor WM diffusion changes compared to HC.
  • Significant correlations between WM connectivity deficits (corpus callosum, anterior internal capsules) and cognitive impairments were observed exclusively in aMCI-MD.

Conclusions:

  • WM degeneration is extensive in aMCI-MD, preceding Alzheimer's disease development.
  • WM pathology in aMCI-SD appears minimal or undetectable with current methods.
  • aMCI is a heterogeneous condition, not a uniform disease entity, with distinct progression patterns based on domain involvement.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dissociative Amnesia01:21

Dissociative Amnesia

Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...